Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department

Clinical Infectious Diseases

Volumn 62, Issue 9, 2016, Pages 1059-1065

  Hsieh, Yu Hsiang ^a   Rothman, Richard E ^a   Laeyendecker, Oliver B ^b   Kelen, Gabor D ^a   Avornu, Ama ^a   Patel, Eshan U ^b   Kim, Jim ^a   Irvin, Risha ^a   Thomas, David L ^a   Quinn, Thomas C ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

CDC recommendations; emergency department; HCV; HCV testing; undiagnosed infection

Indexed keywords

HEPATITIS C ANTIBODY;

ADULT; ARTICLE; DRUG USE; EMERGENCY WARD; EVALUATION STUDY; FEMALE; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION CONTROL; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; SCREENING TEST; SEROPREVALENCE; SEX DIFFERENCE; URBAN AREA; ADOLESCENT; AGED; BLOOD; HEPACIVIRUS; HEPATITIS C; HOSPITAL; HOSPITAL EMERGENCY SERVICE; IMMUNOLOGY; MASS SCREENING; PROCEDURES; PUBLIC HEALTH SERVICE; STANDARDS; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); EMERGENCY SERVICE, HOSPITAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HOSPITALS, URBAN; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84966460725     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw074     Document Type: Article

References (28)

1. Ly K, Xing J, Klevens R, Jiles R, Ward J, Holmberg S. The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med 2012; 156:271-8.
2. Denniston M, Jiles R, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014; 160:293-300.
3. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47(RR-19):1-39.
4. Smith B, Morgan R, Beckett G, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Morb Mortal Wkly Rep 2012; 61(RR-4):1-32.
5. Moyer V; U.S. Preventive Services Task Force. Screening for HIV: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013; 159:51-60.
6. Kelen G, Green G, Purcell R, et al. Hepatitis B and hepatitis C in emergency department patients. N Engl J Med 1992; 326:1399-404.
7. Bansal J, Constantine N, Zhang X, Callahan J, Wasserman S, Marsiglia V. Multiple blood-borne and sexually transmitted infections in sexually transmitted disease clinic and hospital emergency room patient populations. Sex Transm Dis 1993; 20:220-6.
8. Brillman J, Crandall C, Florence C, Jacobs J. Prevalence and risk factors associated with hepatitis C in ED patients. Am J Emerg Med 2002; 20:476-80.
9. Galbraith J, Donnelly J, Franco R, Overton E, Rodgers J, Wang H. National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States. Clin Infect Dis 2014; 59:755-64.
10. Galbraith J, Franco R, Donnelly J, et al. Unrecognized chronic hepatitis C virus infection among baby boomers in the emergency department. Hepatology 2015; 61:776-82.
11. Branson B, Handsfield H, Lampe M, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep 2006; 55(RR-14):1-17.
12. Hsieh Y, Rothman R, Bartlett J, Yang S, Kelen G. HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections. J Acquir Immune Defic Syndr 2008; 49:398-405.
13. Hsieh Y, Kelen G, Laeyendecker O, Kraus C, Quinn T, Rothman R. HIV care continuum for HIV-infected emergency department patients in an inner-city academic emergency department. Ann Emerg Med 2015; 66:69-78.
14. Laeyendecker O, Rothman R, Henson C, et al. The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins Hospital emergency department. J Acquir Immune Defic Syndr 2008; 48:211-5.
15. International Consortium for Blood Safety. Evaluation results of some commercially available anti-HCV test kits used in countries with limited resources. Available at: http://www.icbs-web.org/ICBS-PEI-table3.pdf. Accessed 11 November 2015.
16. Conrad C, Bradley H, Broz D, et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone-Indiana, 2015. MMWR Morb Mortal Wkly Rep 2015; 64:443-4.
17. Zibbell J, Iqbal K, Patel R, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ?30 years-Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep 2015; 64:453-8.
18. Linas B, Barter D, Leff J, et al. The hepatitis C cascade of care: identifying priorities to improve clinical outcomes. PLoS One 2014; 9:e97317.
19. McGowan C, Monis A, Bacon B, et al. A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care. Hepatology 2013; 57:1325-32.
20. Morrill J, Shrestha M, Grant R. Barriers to the treatment of hepatitis C: patient, provider, and system factors. J Gen Intern Med 2005; 20:754-8.
21. Lebovics E, Czobor K. Screening, diagnosis, treatment, and management of hepatitis C: a novel, comprehensive, online resource center for primary care providers and specialists. Am J Med 2014; 127:e11-4.
22. Kwong J, Epstein R. Expanding capacity for hepatitis C treatment in the United States: team-based care and use of nonphysician providers. J Int Assoc Provid AIDS Care 2015; 14:112-5.
23. Mitruka K, Thornton K, Cusick S, et al. Expanding primary care capacity to treat hepatitis C virus infection through an evidence-based care model-Arizona and Utah, 2012-2014. MMWR Morb Mortal Wkly Rep 2014; 63: 393-8.
24. Sulkowski M. Hepatitis C virus infection in HIV-infected patients. Curr Infect Dis Rep 2007; 3:469-76.
25. Holtzman D, Barry V, Ouellet L, et al. The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004. Prev Med 2009; 49:68-73.
26. Latkin C, Davey M, Hua W. Needle exchange program utilization and entry into drug user treatment: is there a long-term connection in Baltimore, Maryland? Subst Use Misuse 2006; 41:1991-2001.
27. Lyons M, Kunnathur V, Rouster S, Hart K, Sperling M, Sherman K. Prevalence of hepatitis C virus infection in an unselected Midwestern emergency department population. In: 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care. Arlington, VA, 2015:22-3. Available at: http://www. hivforum.org/storage/documents/2015/Summit/ebook-nationalsummit2015.pdf. Accessed 25 June 2015.
28. White D, Anderson E, Pfeil S, Trivedi T, Alter H. Results of a rapid hepatitis C virus screening and diagnostic testing program in an urban emergency department. In: 2015 National Summit on HCV and HIV Diagnosis, Prevention and Access to Care. Arlington, VA, 2015: 43. Available at: http://www.hivforum.org/storage/documents/2015/Summit/ebook-nationalsummit2015.pdf. Accessed 25 June 2015.